Timing of Initiation of Low Molecular Weight Heparin Administration in Pregnant Women With Antiphospholipid Syndrome

Trial Profile

Timing of Initiation of Low Molecular Weight Heparin Administration in Pregnant Women With Antiphospholipid Syndrome

Completed
Phase of Trial: Phase IV

Latest Information Update: 01 Dec 2017

At a glance

  • Drugs Enoxaparin sodium (Primary)
  • Indications Antiphospholipid syndrome
  • Focus Therapeutic Use
  • Most Recent Events

    • 03 Jun 2017 Status changed from recruiting to completed.
    • 18 Nov 2016 Planned End Date changed from 1 Dec 2016 to 1 Mar 2017.
    • 18 Nov 2016 Planned primary completion date changed from 1 Sep 2016 to 1 Jan 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top